Document
IPR2013-00371, No. 2051 Exhibit - 2051 Augmentin XR Product Label approved 25 Sep 2002pdf (P.T.A.B. Mar. 10, 2014)
Cite Document
IPR2013-00371, No. 2051 Exhibit - 2051 Augmentin XR Product Label approved 25 Sep 2002pdf (P.T.A.B. Mar. 10, 2014)
+ More Snippets
Document
IPR2013-00371, No. 2069 Exhibit - 2069 Figure of Oraceass Product Logopdf (P.T.A.B. Mar. 10, 2014)
Cite Document
IPR2013-00371, No. 2069 Exhibit - 2069 Figure of Oraceass Product Logopdf (P.T.A.B. Mar. 10, 2014)
+ More Snippets
Document
IPR2013-00371, No. 2124 Exhibit - 2124 REDACTED Excerpt form NDA No 50 805pdf (P.T.A.B. Mar. 10, 2014)
Cite Document
IPR2013-00371, No. 2124 Exhibit - 2124 REDACTED Excerpt form NDA No 50 805pdf (P.T.A.B. Mar. 10, 2014)
+ More Snippets
Document
IPR2013-00371, No. 2128 Exhibit - 2128 REDACTED Document entitled Status Manufacturingpdf (P.T.A.B. Mar. 10, 2014)
Cite Document
IPR2013-00371, No. 2128 Exhibit - 2128 REDACTED Document entitled Status Manufacturingpdf (P.T.A.B. Mar. 10, 2014)
+ More Snippets
Document
IPR2013-00371, No. 2185 Exhibit - Exhibit 2185 Gilmore deposition D Del (P.T.A.B. Jun. 30, 2014)
Cite Document
IPR2013-00371, No. 2185 Exhibit - Exhibit 2185 Gilmore deposition D Del (P.T.A.B. Jun. 30, 2014)
+ More Snippets
Document
IPR2013-00371, No. 2011-2 Exhibit - Substitute Exhibit 2011 (P.T.A.B. Jan. 14, 2014)
Cite Document
IPR2013-00371, No. 2011-2 Exhibit - Substitute Exhibit 2011 (P.T.A.B. Jan. 14, 2014)
+ More Snippets
Document
IPR2013-00371, No. 1006 Exhibit - File history of US Patent No 8,206,740 (P.T.A.B. Jun. 20, 2013)
Cite Document
IPR2013-00371, No. 1006 Exhibit - File history of US Patent No 8,206,740 (P.T.A.B. Jun. 20, 2013)
+ More Snippets
Document
IPR2013-00371, No. 1034 Exhibit - hollmer v harari (P.T.A.B. May. 23, 2014)
Cite Document
IPR2013-00371, No. 1034 Exhibit - hollmer v harari (P.T.A.B. May. 23, 2014)
+ More Snippets
Document
IPR2013-00371, No. 2111 Exhibit - 2111 Del Rosso, et al, Comparison of Anti Inflammatory Dose Rosaceapdf (P.T.A.B. Mar. 10, 2014)
Cite Document
IPR2013-00371, No. 2111 Exhibit - 2111 Del Rosso, et al, Comparison of Anti Inflammatory Dose Rosaceapdf (P.T.A.B. Mar. 10, 2014)
+ More Snippets
Document
IPR2013-00371, No. 2099 Exhibit - 2099 Galderma Laboratories, LPs Oraceapdf (P.T.A.B. Mar. 10, 2014)
Cite Document
IPR2013-00371, No. 2099 Exhibit - 2099 Galderma Laboratories, LPs Oraceapdf (P.T.A.B. Mar. 10, 2014)
+ More Snippets
Document
IPR2013-00371, No. 2047 Exhibit - 2047 Skelly, JP et al, Scaleup of Oral Extended Release Dosage Formspdf (P.T.A.B. Mar. 10, 2014)
Cite Document
IPR2013-00371, No. 2047 Exhibit - 2047 Skelly, JP et al, Scaleup of Oral Extended Release Dosage Formspdf (P.T.A.B. Mar. 10, 2014)
+ More Snippets
Document
IPR2013-00371, No. 2198 Exhibit - Exhibit 2198 REDACTED Exhibit 1082 CONF Oracea P and L 2010 (P.T.A.B. Jun. 30, 2014)
Cite Document
IPR2013-00371, No. 2198 Exhibit - Exhibit 2198 REDACTED Exhibit 1082 CONF Oracea P and L 2010 (P.T.A.B. Jun. 30, 2014)
+ More Snippets
Document
IPR2013-00371, No. 2097 Exhibit - 2097 Galderma Press Releasepdf (P.T.A.B. Mar. 10, 2014)
Cite Document
IPR2013-00371, No. 2097 Exhibit - 2097 Galderma Press Releasepdf (P.T.A.B. Mar. 10, 2014)
+ More Snippets
Document
IPR2013-00371, No. 2079 Exhibit - 2079 Fomulary Tier Status Data, dated October 22, 2010pdf (P.T.A.B. Mar. 10, 2014)
Cite Document
IPR2013-00371, No. 2079 Exhibit - 2079 Fomulary Tier Status Data, dated October 22, 2010pdf (P.T.A.B. Mar. 10, 2014)
+ More Snippets
Document
IPR2013-00371, No. 2019 Exhibit - Exh 2019 CV of Edward M Rudnic (P.T.A.B. Mar. 10, 2014)
Cite Document
IPR2013-00371, No. 2019 Exhibit - Exh 2019 CV of Edward M Rudnic (P.T.A.B. Mar. 10, 2014)
+ More Snippets